Original articleClinical endoscopyA closer look at same-day bidirectional endoscopy
Section snippets
Methods
The Clinical Outcomes Research Initiative (CORI) provided the data for this study. CORI is a national endoscopic database that was developed in 1995 to study the outcomes of endoscopic procedures. This database has been an exceptional resource for promoting endoscopic clinical research. Gastroenterologists generate a computerized endoscopic report. Deidentified report data are electronically transmitted to a central repository. These data are then merged with reports from all sites and are
Results
During the study period, 591,074 unique patients had upper or lower endoscopy. A total of 66,265 patients (11.2%) had same-day BDE. Table 1 demonstrates the demographics of patients receiving BDE performed on the same day.
The most common EGD indications among these 66,265 patients undergoing BDE were reflux/heartburn (29.8%) and abdominal pain/bloating/dyspepsia (27.2%) (Table 2). Of note, multiple indications may have been checked in the endoscopy report.
The most common colonoscopy indications
Discussion
More than 10% of unique patients undergoing upper or lower endoscopy receive same-day BDE. In the majority of cases, there is a distinct and separate indication for each procedure. For example, a patient with reflux may also be receiving a screening colonoscopy. We suspect that the bidirectional examinations were commonly performed for patient convenience and to minimize exposure to conscious sedation to 1 occurrence. We studied a subgroup of patients who had a single specific indication for
References (17)
- et al.
Yield of dual endoscopy for positive fecal occult blood test
Am J Gastroenterol
(2003) - et al.
Endoscopic evaluation of patients with dyspepsia: results from the National Endoscopic Data Repository
Gastroenterology
(2004) - et al.
Gender differences in colorectal polyps and tumors
Am J Gastroenterol
(2001) - et al.
Is upper gastrointestinal endoscopy indicated in asymptomatic patients with a positive fecal occult blood test and negative colonoscopy?
Am J Med
(1999) - et al.
The role of enoscopy in dyspepsia
Gastrointest Endosc
(2001) American Gastroenterological Association medical position statement: evaluation and management of occult and obscure gastrointestinal bleeding
Gastroenterology
(2000)- et al.
Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia
N Engl J Med
(1993) - et al.
Synchronous upper and lower gastrointestinal endoscopy is an effective method of investigating iron-deficiency anaemia
Br J Surg
(1998)
Cited by (32)
Upper GI endoscopy in subjects with positive fecal occult blood test undergoing colonoscopy: systematic review and meta-analysis
2023, Gastrointestinal EndoscopyBundling in medicare patients undergoing bidirectional endoscopy: How often does it happen?
2014, Clinical Gastroenterology and HepatologyCitation Excerpt :To our knowledge, only 1 study has evaluated the use of bundled procedures in a large database. It used data from the Clinical Outcomes Research Initiative endoscopic database9 and examined the frequency of same-day bidirectional endoscopy. This practice, encompassing 11.2% of all upper and lower endoscopies, was performed most frequently for the evaluation of anemia, positive fecal occult blood testing, or abdominal pain.
EUS in the initial assessment of upper abdominal pain: Time for a paradigm shift?
2010, Gastrointestinal EndoscopyPerformance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract
2011, CMAJ. Canadian Medical Association JournalEditorial: concurrence of coeliac disease with inflammatory bowel disease – is big data the final arbiter?
2023, Alimentary Pharmacology and Therapeutics
DISCLOSURE: All authors disclosed no financial relationships relevant to this publication. D. A. Lieberman is the executive director of CORI, a nonprofit organization that receives funding from federal and industry sources. The CORI database was used in this study. This potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee.
Grant Support: This project was supported with funding from NIDDK UO1 CA 89389-01 and the American Cancer Society. In addition, the practice network (Clinical Outcomes Research Initiative) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Bard International, Pentax USA, ProVation, Endosoft, GIVEN Imaging, and Ethicon. The commercial entities had no involvement in this research. Dr. Lieberman is the executive director of the Clinical Outcomes Research Initiative (CORI), a non-profit organization that receives funding from federal and industry sources. The CORI database is used in this study. This potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee. This project was supported with funding from NIDDK UO1 CA 89389-01 and the American Cancer Society. In addition, the practice network (CORI) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Bard International, Pentax USA, ProVation, Endosoft, GIVEN Imaging, and Ethicon. The commercial entities had no involvement in this research.
If you want to chat with an author of this article, you may contact him at [email protected].